Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanxi Tongda Pharmaceutical is a comprehensive pharmaceutical manufacturing company based in Datong, Shanxi Province, China. As a subsidiary of Sinopharm Modern Pharmaceutical Co., Ltd., it is part of the state-owned China National Pharmaceutical Group (Sinopharm). The company specializes in the development and large-scale production of chemical generic drugs, with a product portfolio that includes tablets, capsules, and small-volume injections. Its primary therapeutic focus areas are cardiovascular diseases, metabolic disorders, and anti-infectives. Shanxi Tongda operates modern, GMP-certified facilities and serves as a key production base for essential medicines within the Sinopharm network. The company is committed to providing high-quality, affordable healthcare solutions to the domestic Chinese market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 山西同达药业.